Blood Flow Restriction Exercise for Multiple Sclerosis
(BRAVe-MS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new exercise method called blood flow restriction (BFR) training for people with multiple sclerosis (MS) who have trouble walking or use a wheelchair. BFR training uses a device that partially blocks blood flow to boost muscle strength with less intense workouts. The goal is to improve strength, mobility, fatigue, and quality of life in those with significant MS-related disabilities. Participants should have MS and need assistance walking or use a wheelchair. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance daily living for those with MS.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have had changes to your MS-related drug therapy in the month before joining, you may not be eligible.
What prior data suggests that blood flow restriction exercise is safe for people with advanced disability due to MS?
Research shows that low-load exercise with blood flow restriction (BFR) is generally safe for people with multiple sclerosis (MS). Studies have found that this type of exercise can boost muscle strength and reduce tiredness without causing major side effects. People with MS who have tried BFR report feeling more active and better overall.
In past studies, most participants handled BFR well, experiencing no serious issues. This is crucial for people with MS, especially those with more severe symptoms, as they may find intense workouts difficult. BFR allows them to benefit from easier, lower-intensity exercise.
Overall, BFR training seems to be a promising way to improve life quality for people with advanced MS. However, consulting a healthcare provider before starting any new exercise routine is important.12345Why are researchers excited about this trial?
Researchers are excited about the potential of low-load exercise with blood flow restriction (BFR) for multiple sclerosis (MS) because it offers a new approach to improving muscle strength and function without the need for heavy weights. Unlike traditional MS treatments, which often focus on medications like disease-modifying therapies to slow disease progression, this method uses a novel technique of combining light resistance exercises with controlled blood flow restriction. This could make exercise more accessible for individuals with MS who may struggle with high-intensity workouts, potentially leading to better adherence and outcomes. The supervised BFR approach may enhance the benefits of exercise by maximizing muscle activation and strength gains, offering a promising complementary strategy to existing MS management options.
What evidence suggests that blood flow restriction exercise is effective for multiple sclerosis?
Research has shown that using blood flow restriction (BFR) during light exercise can benefit people with multiple sclerosis (MS). In this trial, one group will perform low-load exercise with BFR, which studies have found strengthens leg muscles in people with MS. This training is promising because it builds strength without requiring intense workouts, which can be challenging for those with severe MS-related disabilities. Additionally, BFR training has reduced fatigue and increased overall physical activity. These benefits suggest that BFR could effectively strengthen muscles and improve the quality of life for people with advanced MS.13467
Who Is on the Research Team?
Mark M Manago, PT
Principal Investigator
Rocky Mountain Regional VA Medical Center, Aurora, CO
Are You a Good Fit for This Trial?
This trial is for Veterans aged 18-75 with a confirmed MS diagnosis who need assistance to walk or use a wheelchair but can sit in one for over an hour. They should not have severe cognitive issues, recent blood clots, extremely high blood pressure, intense leg muscle stiffness, or be on certain MS treatments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo low-load resistance training with or without blood flow restriction for 10 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Low-Load Exercise Control Group
- Low-Load Exercise with Blood Flow Restriction
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor